TY - JOUR
T1 - Nodal marginal zone lymphoma
T2 - Current knowledge and future directions of an heterogeneous disease
AU - Arcaini, Luca
AU - Lucioni, Marco
AU - Boveri, Emanuela
AU - Paulli, Marco
PY - 2009/9
Y1 - 2009/9
N2 - Nodal marginal zone lymphoma (NMZL) is a defined, separate clinicopathological entity. NMZL is a B-cell neoplasm originated in the lymph node, whose histology resembles the nodal infiltration by mucosa-associated lymphoid tissue- or splenic-type marginal zone lymphoma, in the absence of clinical evidence of extranodal or spleen disease. The lack of characteristic phenotypic or molecular diagnostic findings is still hampering the reproducibility of this diagnosis. Herein, we review the main morphological and immunophenotypical markers, discussing the differential with other overlapping entities. We also summarize the clinical features and outcome of this rare lymphoma and we discuss the possible association with hepatitis C virus infection.
AB - Nodal marginal zone lymphoma (NMZL) is a defined, separate clinicopathological entity. NMZL is a B-cell neoplasm originated in the lymph node, whose histology resembles the nodal infiltration by mucosa-associated lymphoid tissue- or splenic-type marginal zone lymphoma, in the absence of clinical evidence of extranodal or spleen disease. The lack of characteristic phenotypic or molecular diagnostic findings is still hampering the reproducibility of this diagnosis. Herein, we review the main morphological and immunophenotypical markers, discussing the differential with other overlapping entities. We also summarize the clinical features and outcome of this rare lymphoma and we discuss the possible association with hepatitis C virus infection.
KW - Hepatitis C virus
KW - Histology
KW - Nodal marginal zone lymphoma
KW - Prognosis
KW - Treatment
UR - http://www.scopus.com/inward/record.url?scp=68849108015&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=68849108015&partnerID=8YFLogxK
U2 - 10.1111/j.1600-0609.2009.01301.x
DO - 10.1111/j.1600-0609.2009.01301.x
M3 - Article
C2 - 19548917
AN - SCOPUS:68849108015
VL - 83
SP - 165
EP - 174
JO - European Journal of Haematology
JF - European Journal of Haematology
SN - 0902-4441
IS - 3
ER -